Kane O'Malley/LinkedIn
Jun 5, 2026, 14:08
Kane O’Malley: Challenging Established Sample Handling Practices in Coagulation Diagnostics
Kane O’Malley, Specialist Biomedical Scientist at Sheffield Teaching Hospitals NHS Foundation Trust, shared a post on LinkedIn:
“I have been fortunate enough to present my MSc project poster today at CLH 2026 UK NEQAS for Blood Coagulation.
I really enjoyed challenging the whole blood stability guidelines for ADAMTS13 TTP and lupus testing for different brands of tubes over 48h.
Conclusions:
- ADAMTS13 activity is highly stable at room temperature for 12h, supporting transport as whole blood without the need for the preparation of frozen plasma, for this method of analysis.
- Only Brand A showed statistically significant change in ADAMTS13 activity at 48h.
- dRVVTs should not be tested after 4h as whole blood, in line with current guidelines, for this method of analysis.
This will help inform procurement of specimen tubes, reduce sample rejection and prevent delaying patient care.
I would like to thank all of my colleagues at Sheffield Teaching Hospitals NHS Foundation Trust and my course leader Dr Chrystelle Egger M at Keele University for you ongoing support.”

Stay updated with Hemostasis Today.
-
Sep 11, 2026, 12:22The First New Treatment for Essential Thrombocythemia in Nearly 30 Years
-
Sep 11, 2026, 12:20When Thrombosis Affects the Kidneys – World Thrombosis Day
-
Sep 11, 2026, 11:24Haroun Gajraj: Polidocanol or STS – Choosing the Right Sclerosant
-
Sep 11, 2026, 10:53A Patient-Centred Approach to Haemophilia B Care – EAHAD
-
Sep 11, 2026, 09:51Alfredo Lozada: Pelacarsen Lowers Lp(a), But Does It Lower CV Risk?
-
Sep 11, 2026, 09:35Yasir Khan: Travel Related Blood Clots – What Are the Chances?
-
Sep 11, 2026, 08:02Mud Alvi: Restarting Antithrombotic Therapy After Hemorrhagic Transformation of Ischemic Stroke
-
Sep 11, 2026, 08:01Chaza Alaji: Factor X From Inherited Deficiency to Acquired Deficiency in AL Amyloidosis
-
Sep 11, 2026, 08:01Mariusz Kowalewski: Risk Stratification of Surgical Ablation During Minimally Invasive Mitral Valve Surgery for AFib